Dacetuzumab
Alternative Names: huS2C6; PRO 64553; RG 3636; S2C6 monoclonal antibody; SGN 14; SGN-40Latest Information Update: 15 Dec 2023
At a glance
- Originator Seattle Genetics
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; CD40 antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chronic lymphocytic leukaemia; Diffuse large B cell lymphoma; Multiple myeloma; Non-Hodgkin's lymphoma